Brown, J. R. (2013). PCI-32765, the First BTK (Bruton’s Tyrosine Kinase) Inhibitor in Clinical Trials.
Dyfyniad Arddull ChicagoBrown, Jennifer R. PCI-32765, the First BTK (Bruton’s Tyrosine Kinase) Inhibitor in Clinical Trials. 2013.
Dyfyniad MLABrown, Jennifer R. PCI-32765, the First BTK (Bruton’s Tyrosine Kinase) Inhibitor in Clinical Trials. 2013.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.